Pilar Solves
Overview
Explore the profile of Pilar Solves including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
344
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chorao P, Pardal A, de Cossio S, Balaguer-Rosello A, Montoro J, Villalba M, et al.
Transplant Cell Ther
. 2025 Mar;
PMID: 40068801
Background: Despite the high incidence of diarrhea in hematopoietic cell transplant (HCT) recipients, data on infectious enterocolitis with post-transplant cyclophosphamide (PTCy) for graft-versus-host disease (GVHD) prophylaxis remain limited. Objectives: Evaluate...
2.
Chorao P, Villalba M, Balaguer-Rosello A, Montoro J, Granados P, Gilabert C, et al.
Transplant Cell Ther
. 2024 Dec;
31(3):182.e1-182.e11.
PMID: 39701290
BK hemorrhagic cystitis (BK-HC) is a common complication following hematopoietic stem cell transplantation (HSCT), particularly when posttransplant cyclophosphamide (PTCy) is used as graft-versus-host disease (GVHD) prophylaxis. However, comparative studies of...
3.
Eiris J, Montoro J, Villalba M, Chorao P, Perez-Bravo M, Rausell N, et al.
Transplant Cell Ther
. 2024 Oct;
31(1):24.e1-24.e12.
PMID: 39424278
Gastrointestinal bleeding (GIB) is a serious complication following allogeneic hematopoietic stem cell transplantation (HSCT), with limited data on its incidence and characteristics, particularly for upper gastrointestinal bleeding (UGIB) of gastric...
4.
Marco-Ayala J, Asensi Canto P, Suarez M, Lamas B, Santiago M, Gomez I, et al.
Transfus Med Rev
. 2024 Oct;
38(4):150859.
PMID: 39383656
Single-unit red blood cell (1-RBC) transfusion policy has shown to effectively reduce transfusion burden while maintaining comparable clinical outcomes in hematological patients compared to the classical double-unit policy. However, its...
5.
Sanz M, Montoro J, Balaguer-Rosello A, Chorao P, Villalba M, Gomez I, et al.
Bone Marrow Transplant
. 2024 Jun;
59(10):1376-1386.
PMID: 38918495
This 45-year study (1978-2022) at a single institution evaluated HSCT outcomes and complications, emphasizing recent advances, with to provide insights into HSCT's evolving field and ongoing efforts to enhance patient...
6.
Cordon L, Chorao P, Martin-Herreros B, Montoro J, Balaguer A, Guerreiro M, et al.
Ann Hematol
. 2024 Apr;
103(7):2475-2484.
PMID: 38634914
This study aimed to investigate the kinetics of immune recovery following umbilical cord blood transplantation (UCBT) in adults who received a myeloablative conditioning (MAC) regimen and antithymocyte globulin (ATG). While...
7.
Chorao P, Henriques M, Villalba M, Montoro J, Balaguer-Rosello A, Gonzalez E, et al.
Transplant Cell Ther
. 2024 Feb;
30(5):538.e1-538.e10.
PMID: 38331195
Cytomegalovirus (CMV) reactivations cause significant morbidity in allogeneic hematopoietic stem cell transplantation (HSCT) recipients. Graft-versus-host disease (GVHD) prophylaxis with post-transplantation cyclophosphamide (PTCy) is associated with an increased risk of CMV...
8.
Balaguer-Rosello A, Gil-Perotin S, Montoro J, Bataller L, Lamas B, Villalba M, et al.
Transplant Cell Ther
. 2023 Jul;
29(10):610.e1-610.e12.
PMID: 37451486
Calcineurin inhibitors (CNIs), including cyclosporine and tacrolimus, are frequently associated with neurologic complications after allogeneic hematopoietic stem cell transplantation (HSCT). However, there is a lack of studies comparing the incidence...
9.
Solves P, Marco-Ayala J, Sanz M, Gomez-Segui I, Balaguer-Rosello A, Facal A, et al.
J Clin Med
. 2023 May;
12(10).
PMID: 37240573
Introduction: Transfusion plays a main role in supportive treatment for patients who receive an allogeneic hematopoietic stem cell transplantation (HSCT). In this study, we compare the transfusion requirements of patients...
10.
Chorao P, Montoro J, Balaguer-Rosello A, Guerreiro M, Villalba M, Facal A, et al.
Transplant Cell Ther
. 2023 Jan;
29(5):322.e1-322.e5.
PMID: 36682469
Bone marrow (BM) is the recommended stem cell source for hematopoietic stem cell transplantation (HSCT) from matched sibling donors (MSDs) in patients with severe aplastic anemia (SAA) for its superior...